Symptoms

Only about 30 % of women with fibroids experience symptoms. The presentation depends on the number, size, and location of the tumors.

Common symptoms

• Heavy or prolonged menstrual bleeding – often leading to anemia.
• Pelvic pressure or pain – a sense of fullness or ache in the lower abdomen.
• Frequent urination – especially when fibroids press on the bladder.
• Constipation or difficulty passing stool – due to pressure on the rectum.
• Painful intercourse (dyspareunia) – especially with submucosal or posterior fibroids.
• Infertility or recurrent pregnancy loss – large or distorting fibroids can affect embryo implantation.
• Lower back pain – when fibroids are located toward the back of the uterus.

Less common but notable symptoms

• Rapid growth of a known fibroid (particularly in pregnancy).
• Acute abdominal pain if a fibroid undergoes torsion, degeneration, or necrosis.
• Bleeding between periods (intermenstrual spotting) when a submucosal fibroid erodes the uterine lining.
• Enlarged abdomen that mimics pregnancy.

Causes and Risk Factors

The exact cause of fibroids is unknown, but several factors appear to influence their development.

Hormonal influences

• Estrogen and progesterone – Fibroids contain more estrogen and progesterone receptors than normal uterine tissue and typically grow during the reproductive years when these hormones are high.
• Growth during pregnancy – Elevated estrogen and progesterone levels can cause rapid enlargement.

Genetic and cellular factors

• Familial clustering suggests a hereditary component; women with a first‑degree relative with fibroids have a 2–3‑fold increased risk.
• Somatic mutations in the MED12 gene are found in up to 70 % of fibroids.

Risk factors

• Age – Risk rises after age 30; peaks in the early 40s.
• Race/ethnicity – African‑American women develop fibroids 2–3 times more often, tend to present at a younger age, and often have larger or more numerous tumors (CDC, 2022).
• Obesity – Higher BMI is linked to increased estrogen production from adipose tissue.
• Early menarche (≤ 10 years) and nulliparity (no pregnancies) raise risk.
• Hypertension – Some studies associate high blood pressure with fibroid growth.
• Diet – High red‑meat consumption and low intake of fruits/vegetables may increase risk, whereas diets rich in green leafy vegetables and vitamin D appear protective.

Diagnosis

Diagnosis begins with a careful history and pelvic exam, followed by imaging if needed.

Physical examination

• During a bimanual exam, a large fibroid may feel like a firm, irregular mass.

Imaging studies

• Transvaginal or pelvic ultrasound – First‑line, inexpensive, and accurate for detecting size, number, and location.
• Magnetic resonance imaging (MRI) – Provides detailed maps of fibroid cellularity and is useful when planning surgery or uterine‑sparing procedures.
• Hysterosonography (saline infusion sonography) – Enhances visualization of submucosal fibroids.
• Hysteroscopy – Direct visual inspection of the uterine cavity; can also allow biopsy or removal of small intracavitary fibroids.

Laboratory tests

• Complete blood count (CBC) to assess anemia from heavy bleeding.
• Serum ferritin/iron studies if chronic blood loss is suspected.
• Pregnancy test before any intervention.

Differential diagnosis

It is essential to rule out other causes of pelvic mass or bleeding, such as adenomyosis, ovarian cysts, endometrial hyperplasia, or malignancy.

Treatment Options

Treatment is individualized based on symptoms, desire for fertility, fibroid size/location, age, and overall health. Options range from watchful waiting to minimally invasive procedures.

1. Watchful waiting (active surveillance)

• Appropriate for small, asymptomatic fibroids.
• Regular follow‑up with ultrasound every 6–12 months.

2. Medications

• Tranexamic acid – Reduces heavy menstrual bleeding (non‑hormonal).
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – Relieve cramping but do not shrink fibroids.
• Gonadotropin‑releasing hormone (GnRH) agonists (e.g., leuprolide) – Induce a temporary menopausal state, shrinking fibroids 30–50 % in 3–6 months; useful pre‑surgery.
• Selective progesterone receptor modulators (SPRMs) (e.g., ulipristal acetate) – Approved in Europe and Canada; reduces size and bleeding with fewer menopausal symptoms than GnRH agonists.
• Progestin‑containing IUD (levonorgestrel‑IUD) – Controls bleeding; does not decrease fibroid size but improves quality of life.
• Oral contraceptives or combined hormonal contraceptives – May modestly reduce menstrual blood loss.

3. Minimally invasive procedures

• Uterine artery embolization (UAE) – Radiologic occlusion of uterine arteries causing fibroid infarction; effective for women who do not desire future pregnancy.
• Magnetic resonance‑guided focused ultrasound (MRgFUS) – External ultrasound waves heat and destroy fibroid tissue under MRI guidance; outpatient, fertility‑preserving.
• Laparoscopic or robotic myomectomy – Surgical removal of fibroids while preserving the uterus; preferred for women seeking pregnancy.
• Hysteroscopic resection – Removes submucosal fibroids via the cervix; often combined with hysteroscopic morcellation devices.

4. Surgical options

• Abdominal (open) myomectomy – For very large or numerous fibroids.
• Total or subtotal hysterectomy – Definitive cure; removal of the uterus (and possibly cervix). Recommended when symptoms are severe, fertility is no longer desired, or other treatments have failed.

5. Lifestyle and supportive measures

• Regular aerobic exercise can lower estrogen levels.
• Maintain a healthy weight (BMI < 25 kg/m²) to reduce hormonal drive.
• Consider a diet rich in fruits, vegetables, and vitamin‑D‑fortified foods.
• Iron supplementation for anemia, under physician guidance.

Living with Fibroid (uterine leiomyoma)

Even when treatment is not immediately required, chronic symptoms can affect daily life. Below are practical tips for managing symptoms:

• Track menstrual bleeding – Use a diary or app to monitor flow, spotting, and associated symptoms; this helps clinicians gauge treatment effectiveness.
• Heat therapy – Warm packs or a heating pad can ease uterine cramping.
• Stress reduction – Chronic stress may influence hormonal balance; mindfulness, yoga, or gentle stretching are beneficial.
• Pain management – Over‑the‑counter NSAIDs (ibuprofen 400–600 mg q6‑8h) are effective for many; always follow dosing limits.
• Iron‑rich diet – Incorporate lean red meat, beans, fortified cereals, spinach, and vitamin C to improve iron absorption.
• Regular follow‑up – Even stable fibroids should be re‑evaluated annually or sooner if symptoms change.
• Fertility planning – If pregnancy is desired, discuss timing of myomectomy or other uterus‑sparing options with a reproductive specialist.

Prevention

No guarantee exists to prevent fibroids, but certain measures may lower risk:

• Maintain a healthy weight – Reduces peripheral estrogen conversion.
• Balanced diet – Emphasize whole grains, legumes, leafy greens, and low‑fat dairy; limit red meat and processed foods.
• Vitamin D optimization – Deficiency is linked to higher fibroid prevalence; aim for 20‑30 ng/mL 25‑OH vitamin D levels (CDC).
• Exercise – At least 150 minutes of moderate aerobic activity per week.
• Smoking cessation – Though data are mixed, smoking is associated with altered hormone metabolism.
• Discuss hormonal contraceptive choices – Some studies suggest that long‑acting reversible contraception (LARC) may modestly reduce fibroid growth, but evidence is not definitive.

Complications

If left untreated or inadequately managed, fibroids can lead to serious health issues:

• Severe anemia from chronic heavy bleeding, causing fatigue, shortness of breath, and impaired work capacity.
• Infertility or recurrent miscarriage – Particularly with submucosal or large, distorting fibroids.
• Pregnancy complications – Preterm labor, malpresentation, placental abruption, or need for cesarean delivery.
• Urinary retention – Large posterior fibroids may compress the urethra.
• Acute abdominal pain – Resulting from torsion, degeneration, or rare malignant transformation (leiomyosarcoma, ≈ 0.1 % of surgically removed fibroids).
• Psychological impact – Chronic pain and heavy bleeding can cause anxiety, depression, and reduced quality of life.

When to Seek Emergency Care

Sources: Mayo Clinic, National Institute of Child Health & Human Development (NICHD), Centers for Disease Control and Prevention (CDC), American College of Obstetricians and Gynecologists (ACOG), World Health Organization (WHO), Cleveland Clinic, peer‑reviewed articles in Obstetrics & Gynecology and The Lancet (2020‑2024).